View the content of this email online

Looking for an efficient CRISPR delivery system ?

LentiFlash™ particles carrying CRISPR-Cas9 technology show promising results to disrupt targeted genes in several therapeutic fields!

Image NL 19

LentiFlash™-CRISPR-Cas9 particles allow efficient KO of genes of interest in human primary T cells for multiple applications such as:

  • Cancer immunotherapy approach (discover data on efficient editing of PD1)
  • Antiviral strategies (discover data on efficient editing of CXCR4)
  • All this by guaranteeing a safe and efficient gene transfer even in primary T cells

To discover the data gathered by Vectalys

Click here

Follow us

Google plus Vectalys Twitter Vectalys LinkedIn Vectalys Youtube Vectalys
© Vectalys 2016 - www.vectalys.com - tech@vectalys.com
Share:
Share facebook Share twitter Share Linkedin Share Google

Click here to unsuscribe from the mailing list